http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
PKF O'Connor Davies Welcomes Rainer & Company
-
Cunard launches 195 new voyages, visiting 115 destinations across the globe
-
Scholar Rock Holding Corp. (SRRK) Appoints as Rebecca McLeod Chief Brand Officer and U.S. General Manager
-
National Comprehensive Cancer Network (NCCN) Updates Colorectal Cancer Screening Guidelines to Include Shield Blood-Based Screening
-
Viatris Inc (VTRS) Announces Positive Top-Line Results from Phase 3 LYNX-2 Trial of MR-142
-
Scholar Rock Appoints Rebecca McLeod Chief Brand Officer and U.S. General Manager
-
TG Therapeutics to Participate in the Jefferies Global Healthcare Conference
-
Operation HOPE and Financial Literacy for All Celebrate Record-Breaking Success of Green Socks Day Challenge
-
Lightbridge Completes Final Experiment Design for Designated ATR Core Position
-
Viatris Announces Positive Top-Line Results from Phase 3 LYNX-2 Trial of MR-142 in Keratorefractive Patients With Visual Disturbances Under Mesopic, Low-Contrast Conditions
-
Toshiba Awarded National Cooperative Contract
-
Context Therapeutics Announces CTIM-76 Trial in Progress Poster Presentation at 2025 ASCO Meeting
-
Auxly Announces Annual General Meeting of Shareholders
-
BridgeBio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025
-
Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-ALK7 for the Treatment of Obesity
-
ReElement Technologies Secures Anchor Investment from South African Firm Novare Holdings to Catalyze Rare Earth Element Refining Expansion in America's Heartland
-
Canadian Gold Corp. Acquires Assigned Option from Searchlight Resources Inc. of Flin Flon North Property, Significantly Expanding Control of the Tartan Shear Zone
-
Dr Manfred Knof joins DeFi Technologies as Chairman of Valour and Strategic Advisor
-
Dow (DOW) to Sell its 50% Ownership in DowAksa Joint Venture
-
Dow Announces Agreement to Sell its 50% Ownership in DowAksa Joint Venture
-
Aclaris Therapeutics (ACRS) Initiates Phase 2 Trial of Bosakitug (ATI-045) in Atopic Dermatitis
-
Relay Therapeutics (RLAY) Announces Updated Data for RLY-2608 + Fulvestrant
-
Zai Lab Limited (ZLAB) Presents Positive Phase 1 Data for ZL-1310
-
Trevi Therapeutics (TRVI) Announces Positive Topline Results from the Phase 2b CORAL Trial
-
CoinNFT Club Launches A New Utility-Focused NFT Marketplace for Creators and Innovators
-
Trevi Therapeutics Announces Positive Topline Results from the Phase 2b CORAL Trial of Haduvio in Patients with Idiopathic Pulmonary Fibrosis Chronic Cough
-
PreveCeutical Welcomes Dr. Deepak Sampath, PhD. as Corporate Advisor
-
Hyundai Named Top Mass-Market Brand in the J.D. Power 2025 U.S. OEM EV App Report for Second Year in a Row
-
SCIEX Sets a New Standard in Accurate Mass Quantitation With the ZenoTOF 8600 System and New Software Collaborations
-
Relay Therapeutics Announces Updated Data for RLY-2608 + Fulvestrant Further Demonstrating Clinically Meaningful Progression Free Survival at ASCO 2025
-
SCIEX and Evosep expand access to standardized proteomics for Pharma and Biotech with new reseller agreement
-
SERENA-6 Phase III Trial Demonstrates Clinical Value of Guardant360 CDx Test to Detect Emergence of Endocrine Resistance and Inform a Switch in Therapy Before Radiological Disease Progression in Advan
-
Zai Lab Presents Positive Phase 1 Data for ZL-1310, a DLL3-Targeted ADC, Demonstrating Robust Anti-Tumor Activity and Safety in Patients with Extensive-Stage Small Cell Lung Cancer at 2025 ASCO Annual
-
Software Launches for SCIEX OS Ecosystem to Help Scientists Accelerate Discoveries and Streamline Lab Operations
-
Anixa Biosciences Announces Completion of Enrollment in Phase 1 Trial of Breast Cancer Vaccine
-
Aclaris Therapeutics Initiates Phase 2 Trial of Bosakitug (ATI-045) in Atopic Dermatitis
-
Gen Q1/2025 Threat Report
-
Stomp Into Some Prehistoric Learning! Lingokids and BBC Earth Launch New Walking With Dinosaurs Lesson to Bring a Love of Dinosaurs to a New Generation
-
GFG Announces Encouraging Phase 1 Drill Results from Pen Gold Project, Ontario
-
Frontera Announces Launch of CAD$91,000,000 Million (Approximately US$65 Million) Substantial Issuer Bid
-
Silo Wellness to Relist as Born Defense, a National Security Investment Issuer Focused on Ending Forever Wars and Upholding the Just War Doctrine
-
Maxar Space Systems Selected to Build High-Power EchoStar XXVI Satellite
-
Harbinger Research Publishes Coverage Initiation Report, on American Diversified Holdings Corporation (ADHC) and Its Operating Division, GlucoGuard
-
Gogoro Announces Results of Annual General Meeting of Shareholders
-
CoinNFT Club Launches A New Utility-Focused NFT Marketplace for Creators and Innovators
-
BROAD ARROW’S EXPANSION IN EUROPE CONTINUES WITH THE ZOUTE CONCOURS AUCTION IN BELGIUM
-
Press Release Biocartis NV: Biocartis Announces IVDR Class C CDx Certification of the Idylla™ EGFR Mutation Test
-
Transgene and NEC Present Durable Disease-Free Survival and Sustained T Cell Responses at 24 months with Individualized Cancer Vaccine TG4050
-
SES’s O3b mPOWER System Receives Platinum Space Sustainability Rating
-
Novartis Pluvicto™ demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive metastatic hormone-sensitive prostate cancer
